Acute Leukemia Archive - Seite 3 von 5 - IOZK

Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: Results of phase I study.

2013-06-01/in Acute Leukemia, Dendritic Cells, International Publications

WT1-targeted dendritic cell vaccination as a postremission treatment to prevent or delay relapse in acute myeloid leukemia.

2012-06-04/in Acute Leukemia, Dendritic Cells, International Publications

[Dendritic cell-based therapeutic vaccination for acute myeloid leukemia]

2012-06-01/in Acute Leukemia, Dendritic Cells, International Publications

Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo

2011-11-30/in Acute Leukemia, International Publications, Newcastle Disease Virus

Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells

2011-08-04/in Acute Leukemia, Dendritic Cells, International Publications

[Roles of Newcastle disease virus in human acute monocytic leukemia in vitro and in vivo]

2011-02-01/in Acute Leukemia, International Publications, Newcastle Disease Virus

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms‘ tumor 1 antigen-targeted dendritic cell vaccination

2010-07-14/in Acute Leukemia, Dendritic Cells, International Publications

Immunotherapy of acute myeloid leukemia: current approaches

2009-03-16/in Acute Leukemia, International Publications

Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response

2009-02-19/in Acute Leukemia, International Publications

Immunotherapy in acute leukemia

2009-01-01/in Acute Leukemia, International Publications